Department of Biological Sciences, University of Calgary, 2500 University Drive N.W., Calgary, Alberta, T2N 1N4, Canada.
Instituto de Genética Médica y Molecular (INGEMM), IdiPAZ and Skeletal dysplasia multidisciplinary unit (UMDE), Hospital Universitario La Paz, Universidad Autónoma de Madrid, P° Castellana 261, 28046, Madrid, Spain.
Sci Rep. 2018 Sep 24;8(1):14292. doi: 10.1038/s41598-018-32565-1.
Haploinsufficiency of the human SHOX gene causes Léri-Weill dyschondrosteosis (LWD), characterized by shortening of the middle segments of the limbs and Madelung deformity of the wrist. As many as 35% of LWD cases are caused by deletions of non-coding sequences downstream of SHOX that presumably remove an enhancer or enhancers necessary for SHOX expression in developing limbs. We searched for these active sequences using a transgenic mouse assay and identified a 563 basepair (bp) enhancer with specific activity in the limb regions where SHOX functions. This enhancer has previously escaped notice because of its poor evolutionary conservation, although it does contain 100 bp that are conserved in non-rodent mammals. A primary cell luciferase assay confirmed the enhancer activity of the conserved core sequence and demonstrated that putative HOX binding sites are required for its activity. This enhancer is removed in most non-coding deletions that cause LWD. However, we did not identify any likely pathogenic variants of the enhancer in a screen of 124 LWD individuals for whom no causative mutation had been found, suggesting that only larger deletions in the region commonly cause LWD. We hypothesize that loss of this enhancer contributes to the pathogenicity of deletions downstream of SHOX.
SHOX 基因单倍不足导致 Léri-Weill 软骨发育不全症(LWD),其特征是四肢中段缩短和腕部 Madelung 畸形。多达 35%的 LWD 病例是由 SHOX 下游非编码序列缺失引起的,这些缺失可能去除了 SHOX 在发育中的四肢中表达所需的增强子或增强子。我们使用转基因小鼠检测方法寻找这些活性序列,并鉴定了一个具有特定活性的 563 碱基对(bp)增强子,该增强子在 SHOX 起作用的肢体区域具有活性。由于其进化保守性差,这个增强子以前一直没有被注意到,尽管它确实包含 100bp 在非啮齿类哺乳动物中是保守的。初级细胞荧光素酶检测证实了保守核心序列的增强子活性,并表明其活性需要假定的 HOX 结合位点。这个增强子在大多数导致 LWD 的非编码缺失中被删除。然而,在对 124 名尚未发现致病突变的 LWD 个体进行的增强子筛选中,我们没有发现任何可能的致病性变异,这表明只有该区域的较大缺失才会导致 LWD。我们假设这个增强子的缺失导致了 SHOX 下游缺失的致病性。